FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2153652099> ?p ?o ?g. }

• W2153652099 endingPage "R82" @default.
• W2153652099 startingPage "R82" @default.
• W2153652099 abstract "Neutrophil granulocytes are the first defense line in bacterial infections. However, granulocytes are also responsible for severe local tissue impairment. In order to use donor granulocytes, but at the same time to avoid local side effects, we developed an extracorporeal immune support system. This first-in-man study investigated whether an extracorporeal plasma treatment with a granulocyte bioreactor is tolerable in patients with septic shock. A further intention was to find suitable efficacy end-points for subsequent controlled trials. The trial was conducted as a prospective uncontrolled clinical phase I/II study with 28-day follow-up at three university hospital intensive care units. Ten consecutive patients (five men, five women, mean age 60.3 ± 13.9 standard deviation (SD) years) with septic shock with mean ICU entrance scores of Acute Physiology and Chronic Health Evaluation (APACHE) II of 29.9 ± 7.2 and of Simplified Acute Physiology Score (SAPS) II of 66.2 ± 19.5 were treated twice within 72 hours for a mean of 342 ± 64 minutes/treatment with an extracorporeal bioreactor containing 1.41 ± 0.43 × 10E10 granulocytes from healthy donors. On average, 9.8 ± 2.3 liters separated plasma were treated by the therapeutic donor cells. Patients were followed up for 28 days. Tolerance and technical safety during treatment, single organ functions pre/post treatment, and hospital survival were monitored. The extracorporeal treatments were well tolerated. During the treatments, the bacterial endotoxin concentration showed significant reduction. Furthermore, noradrenaline dosage could be significantly reduced while mean arterial pressure was stable. Also, C-reactive protein, procalcitonin, and human leukocyte antigen DR (HLA-DR) showed significant improvement. Four patients died in the hospital on days 6, 9, 18 and 40. Six patients could be discharged. The extracorporeal treatment with donor granulocytes appeared to be well tolerated and showed promising efficacy results, encouraging further studies. ClinicalTrials.gov Identifier: NCT00818597" @default.
• W2153652099 created "2016-06-24" @default.
• W2153652099 creator A5001284873 @default.
• W2153652099 creator A5013203088 @default.
• W2153652099 creator A5018527261 @default.
• W2153652099 creator A5027510301 @default.
• W2153652099 creator A5035882446 @default.
• W2153652099 creator A5043147258 @default.
• W2153652099 creator A5044239762 @default.
• W2153652099 creator A5046959059 @default.
• W2153652099 creator A5048188398 @default.
• W2153652099 creator A5053203122 @default.
• W2153652099 creator A5058360849 @default.
• W2153652099 creator A5062399236 @default.
• W2153652099 creator A5064309172 @default.
• W2153652099 creator A5077385681 @default.
• W2153652099 date "2011-01-01" @default.
• W2153652099 modified "2023-10-09" @default.
• W2153652099 title "Extracorporeal cell therapy of septic shock patients with donor granulocytes: a pilot study" @default.
• W2153652099 cites W1512082009 @default.
• W2153652099 cites W1971200468 @default.
• W2153652099 cites W1985368553 @default.
• W2153652099 cites W2011356537 @default.
• W2153652099 cites W2013124466 @default.
• W2153652099 cites W2039145048 @default.
• W2153652099 cites W2041697294 @default.
• W2153652099 cites W2043720588 @default.
• W2153652099 cites W2049927822 @default.
• W2153652099 cites W2054641153 @default.
• W2153652099 cites W2061889502 @default.
• W2153652099 cites W2067970770 @default.
• W2153652099 cites W2085124338 @default.
• W2153652099 cites W2085380448 @default.
• W2153652099 cites W2089296529 @default.
• W2153652099 cites W2090831461 @default.
• W2153652099 cites W2095249660 @default.
• W2153652099 cites W2095545402 @default.
• W2153652099 cites W2096180856 @default.
• W2153652099 cites W2100322726 @default.
• W2153652099 cites W2106611795 @default.
• W2153652099 cites W2113823462 @default.
• W2153652099 cites W2116900376 @default.
• W2153652099 cites W2118858814 @default.
• W2153652099 cites W2125444608 @default.
• W2153652099 cites W2128349740 @default.
• W2153652099 cites W2141416944 @default.
• W2153652099 cites W2155376910 @default.
• W2153652099 cites W2322121630 @default.
• W2153652099 cites W2599527603 @default.
• W2153652099 cites W4241188213 @default.
• W2153652099 cites W4293242440 @default.
• W2153652099 doi "https://doi.org/10.1186/cc10076" @default.
• W2153652099 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3219336" @default.
• W2153652099 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21371308" @default.
• W2153652099 hasPublicationYear "2011" @default.
• W2153652099 type Work @default.
• W2153652099 sameAs 2153652099 @default.
• W2153652099 citedByCount "26" @default.
• W2153652099 countsByYear W21536520992012 @default.
• W2153652099 countsByYear W21536520992013 @default.
• W2153652099 countsByYear W21536520992015 @default.
• W2153652099 countsByYear W21536520992016 @default.
• W2153652099 countsByYear W21536520992017 @default.
• W2153652099 countsByYear W21536520992018 @default.
• W2153652099 countsByYear W21536520992019 @default.
• W2153652099 countsByYear W21536520992020 @default.
• W2153652099 countsByYear W21536520992021 @default.
• W2153652099 countsByYear W21536520992022 @default.
• W2153652099 countsByYear W21536520992023 @default.
• W2153652099 crossrefType "journal-article" @default.
• W2153652099 hasAuthorship W2153652099A5001284873 @default.
• W2153652099 hasAuthorship W2153652099A5013203088 @default.
• W2153652099 hasAuthorship W2153652099A5018527261 @default.
• W2153652099 hasAuthorship W2153652099A5027510301 @default.
• W2153652099 hasAuthorship W2153652099A5035882446 @default.
• W2153652099 hasAuthorship W2153652099A5043147258 @default.
• W2153652099 hasAuthorship W2153652099A5044239762 @default.
• W2153652099 hasAuthorship W2153652099A5046959059 @default.
• W2153652099 hasAuthorship W2153652099A5048188398 @default.
• W2153652099 hasAuthorship W2153652099A5053203122 @default.
• W2153652099 hasAuthorship W2153652099A5058360849 @default.
• W2153652099 hasAuthorship W2153652099A5062399236 @default.
• W2153652099 hasAuthorship W2153652099A5064309172 @default.
• W2153652099 hasAuthorship W2153652099A5077385681 @default.
• W2153652099 hasBestOaLocation W21536520991 @default.
• W2153652099 hasConcept C126322002 @default.
• W2153652099 hasConcept C141071460 @default.
• W2153652099 hasConcept C177713679 @default.
• W2153652099 hasConcept C2776376669 @default.
• W2153652099 hasConcept C2777371824 @default.
• W2153652099 hasConcept C2777628635 @default.
• W2153652099 hasConcept C2777983669 @default.
• W2153652099 hasConcept C2778384902 @default.
• W2153652099 hasConcept C2779915274 @default.
• W2153652099 hasConcept C2780347030 @default.
• W2153652099 hasConcept C2781300812 @default.
• W2153652099 hasConcept C2987404301 @default.
• W2153652099 hasConcept C42219234 @default.

• next